Comparative Efficacy and Safety of Polygel Dual and Other Antacids in the Treatment of Heartburn and Dyspepsia
- Conditions
- Heartburn and Dyspepsia
- Registration Number
- PACTR202311905202771
- Lead Sponsor
- Shalina Healthcare Nigeria Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 240
1.Patients suffering from heartburn and/or regurgitation (more than 2 weekly episodes of heartburn) and indigestion.
2.Patients of both sexes who are 18 years and above.
3.Patients not on proton pump inhibitors (PPI) or H2-receptor antagonists in 7 days or any other antacids in the last 3 days
4.Patients willing to provide written informed consent
1.Contraindications for the ingredients present in Polygel Dual and other study medications as per approved local prescribing information.
2.Any reasons of medical and non-medical character, which in the opinion of the physician can prevent participant participation in the study.
3.Pregnant or nursing women
4.Patients treated with non-steroidal anti-inflammatory drugs (NSAIDs) or steroids.
5.Patients with confirmed organic disease at upper GI endoscopy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method